Contents:
Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the bypass angioplasty revascularization investigation BARI. The power of collateral circulation: a case of asymptomatic chronic total occlusion of the left main coronary artery. J Invas Cardiol.
Comparison of outcomes between bare metal stents and drug-eluting stents for percutaneous revascularization of internal mammary grafts. Am J Cardiol. Establishment of an animal model of vascular restenosis with bilateral carotid artery grafting. Gibbon JH Jr. The development of the heart-lung apparatus. Am J Surg. Internal mammary artery graft angioplasty: acute and long-term outcome. Catheter Cardiovasc Diagn. Histological appearances of the long saphenous vein.
J Pathol. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. Comparison of slice multidetector spiral computed tomography with angiography in displaying conduits after coronary artery bypass grafting. J Chin Pract Diagn Ther.
Incomplete revascularization reduces survival benefit of coronary artery bypass grafting: role of off-pump surgery. Surgical revascularization techniques that minimize surgical risk and maximize late survival after coronary artery bypass grafting in patients with diabetes mellitus. Does grafting coronary arteries with only moderate stenosis affect long-term mortality?
Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator. Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure. J Vasc Surg. Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial.
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. ECM-related gene expression profile in vascular smooth muscle cells from human saphenous vein and internal thoracic artery. J Cardiothorac Surg. Differential expression of tissue-type plasminogen activator in restenosis animal blood vessel. Chin J Biomed Eng.
Prevention and treatment of the t-PA gene transfection for restenosis after revascularization. J Qiqihar Med Coll.
Cardiac-targeting transfection of tissue-type plasminogen activator gene to prevent the graft thrombosis and vascular anastomotic restenosis after coronary bypass. Thromb Res. Download references. RL and BL conceived the study, study design, and participated in literature search. RL performed data analysis, data interpretation, and wrote the manuscript. BL revised the manuscript. All authors read and approved the final manuscript. The datasets in the current study are available from the corresponding author under reasonable request. Patients provided informed consent. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Correspondence to Ruixiong Li or Bin Lan. Reprints and Permissions. Search all BMC articles Search.
Abstract Objective To explore the feasibility and safety of using tissue-type plasminogen activator t-PA to prevent graft restenosis after coronary artery bypass grafting CABG. Background Coronary artery bypass grafting CABG is widely used for the treatment of coronary heart disease CHD and remains the most common form of cardiac surgery [ 1 ].
Patients and methods Patients In this prospective observational study, 37 patients who underwent elective off-pump beating heart coronary artery bypass surgery at the Shantou Central Hospital and Affiliated Shantou Hospital of Sun Yat-sen University between June and May were included.
Local delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries. Hum Gene Ther. Her download and education buildings have Energy-Environment-Economy industry paper, km rate, water support, Energy and substantial annum. During a heart attack, blood supply that normally nourishes the heart with oxygen is cut off and the heart muscle begins to die. Thus, the study demonstrates the feasibility of site-specific drug delivery to implanted magnetizable stents by uniform field-controlled targeting of magnetic nanoparticles with efficacy for ISR.
Statistical analysis Continuous data were presented as means and standard deviations SD and were compared with independent samples t test. References 1. Article PubMed Google Scholar 6. Article PubMed Google Scholar 8. Article PubMed Google Scholar Google Scholar CAS Google Scholar Article Google Scholar Acknowledgements None. Competing interests The authors declare that they have no competing interests. Availability of data and materials The datasets in the current study are available from the corresponding author under reasonable request. Consent for publication All authors agree to publish this work under the current authorship.
About this article. Contact us Submission enquiries: Access here and click Contact Us General enquiries: info biomedcentral. Kudenchuk, W. Brown, E. Thrombolytic Therapy in Elderly Patients; M. Mooradd, R. Goldberg, J. Jain, F. Wackers, B. Bovill, R.
Tracy, C. Granger, N. Future of Coronary Thrombolysis; B. Du kanske gillar. Lifespan David Sinclair Inbunden. Spara som favorit.
Dx/Rx: Coronary Thrombosis: Richard Becker, Frederick Spencer: Books - giuliettasprint.konfer.eu Dx/Rx Coronary Thrombosis [Richard C Becker] on giuliettasprint.konfer.eu *FREE* shipping on eligible orders. Tightly Organized Into A Super-Condensed Outline.